-

QT Imaging to Participate in the 17th Annual Craig-Hallum Alpha Select Conference

PETALUMA, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announces that it will participate in the 17th Annual Craig-Hallum Alpha Select Conference, taking place today, November 17, 2026, at the Sheraton New York Times Square Hotel in New York City.

Members of QT Imaging's management team will participate in one-on-one meetings with institutional investors throughout the day. Details are as follows:

Event:

17th Annual Craig-Hallum Alpha Select Conference

Date:

Tuesday, November 17, 2026

Location:

Sheraton New York Times Square Hotel, New York, NY

Format:

One-on-one investor meetings

About QT Imaging

QT Imaging Holdings, Inc. (Nasdaq: QTI) is a medical device company engaged in the research, development, and commercialization of innovative imaging systems that use low-frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the Company’s website at www.qtimaging.com and follow us on LinkedIn.

Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.

Contacts

Investors
CORE IR
Tirth Patel
ir@qtimaging.com
386-295-2215

Media
CORE IR
Matthew Cossel
pr@qtimaging.com
212-655-0924

QT Imaging Holdings, Inc.

NASDAQ:QTI

Release Versions
$Cashtags

Contacts

Investors
CORE IR
Tirth Patel
ir@qtimaging.com
386-295-2215

Media
CORE IR
Matthew Cossel
pr@qtimaging.com
212-655-0924

Social Media Profiles
More News From QT Imaging Holdings, Inc.

QT Imaging Reports 75% Third Quarter Revenue Growth and Major Medicare Reimbursement Milestone

PETALUMA, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and nine months ended September 30, 2026, and provided a business update. “Our third-quarter results demonstrate the continued growth of QT Imaging, with revenue increasing 75% year over year and reaching $21.3 mi...

QT Imaging Secures First GCC Commercial Order from American Hospital Dubai, Plans Clinical Research Collaboration

PETALUMA, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced its first commercial order in the Gulf Cooperation Council (GCC) region for the QT Imaging Breast Acoustic CT™ scanner from American Hospital Dubai, through its regional distribution partner, Al Naghi Medical. “American Hospital Dubai is precis...

QT Imaging Secures Medicare Outpatient Reimbursement for QTscan®, Effective January 2027

PETALUMA, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has established a separately payable Medicare hospital outpatient classification for diagnostic QTscan® examinations, effective January 1, 2027. CMS recognized that QTscan diagnostic s...
Back to Newsroom